Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kestra Medical Technologies Ltd shares valued at $289,000 were purchased by COHEN RAYMOND W on Mar 07 ’25. At $17.00 per share, COHEN RAYMOND W acquired 17,000 shares. The insider’s holdings grew to 29,994 shares worth approximately $0.83 million following the completion of this transaction.
As published in their initiating research note from BTIG Research on November 18, 2025, Kestra Medical Technologies Ltd [KMTS] has been a Buy and the price target has been revised to $32. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in late March. As of March 31, 2025, Wells Fargo has initiated its “an Overweight” rating for KMTS. Earlier on March 31, 2025, Stifel initiated its rating. Their recommendation was “a Buy” for KMTS stock.
Analyzing KMTS Stock Performance
On last trading session, Kestra Medical Technologies Ltd [NASDAQ: KMTS] plunged -0.11% to $27.52. The stock’s lowest price that day was $26.9, but it reached a high of $27.9602 in the same session. During the last five days, there has been a surge of approximately 2.61%.
Support And Resistance Levels for Kestra Medical Technologies Ltd (KMTS)
According to the 24-hour chart, there is a support level at 26.96, which, if violated, would cause prices to drop to 26.40. In the upper region, resistance lies at 28.02. The next price resistance is at 28.52. RSI (Relative Strength Index) is 58.70 on the 14-day chart, showing neutral technical sentiment.
Is Kestra Medical Technologies Ltd subject to short interest?
Stocks of Kestra Medical Technologies Ltd saw a sharp rise in short interest on 2025-11-28 jumping by 0.31 million shares to 1.95 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.64 million shares. A jump of 15.92% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.8 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.8.
Which companies own the most shares of Kestra Medical Technologies Ltd (KMTS)?
In terms of Kestra Medical Technologies Ltd share price expectations, FactSet research, analysts set an average price target of 29 in the next 12 months, up nearly 5.26% from the previous closing price of $27.55. Analysts anticipate Kestra Medical Technologies Ltd stock to reach 30 by 2025, with the lowest price target being 25. On March 31, 2025, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $27.
